Supplemental Figure 1 A B C.

Slides:

Advertisements

Similar presentations

Supplemental Figure 1 a % pulldown from input LNCaP/scrambled-siRNA Figure 1 A, ChIP analysis of AR and PHB binding to the PSA promoter in the LNCaP/scrambled-siRNA.

Advertisements

Supplementary Figure 1. Caspase 8 expression and activation and Fas expression in NSCLC and normal lung cell lines. A Western blot analysis of DR4 and.

Supplemental figure 1 ROS production in MM cell line (KMM1) treated with bortezomib and DCA. ROS production was marginally increased by DCA in combination.

Supplemental Figure 1 A No. at risk T T T

Figure 1 HuR Tis11b HPRT VEGF Time (h) A 462 bp (VEGF 165 ) 332 bp (VEGF 121 ) 354 bp 111 bp 305 bp.

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

Supplement Figure 1A. Representative 2D gel image of normal whey with 32 differently expressed protein spots identified by peptide mass fingerprinting.

Supplemental Results Online Figure S1. Norepinephrine increases ROS production. (A): H9c2 cells were treated with 10  M norepinephrine and intracellular.

ADT, Estramustine, Dexamethasone Prednisolone Radiotherapy (Months) (ng/mL) PSA Time Patient A Patient B Patient.

Scientific Notation. Write the following numbers in scientific notation: Ex:3,700,000 km ___________________________ Ex: g ________________________.

Supplemental Table 1 Source and authentication of cell lines.

Ex Vivo Gene Therapy Using Patient iPSC-Derived NSCs Reverses Pathology in the Brain of a Homologous Mouse Model Tagan A. Griffin, Hayley C. Anderson,

Supplemental Figure 1. Erlotinib does not alter oxygenation of tumors. Tumor pO 2 was measured by phosphorescence lifetime oximetry at times before erlotinib.

Supplemental Digital Content Figure 1A A Academic/Research Program Extent of Lung Resection No. of SubjectEventCensored Median Survival (95% CI)60 mo Survival.

Supplementary Figure 1. The effect of 17-DMAG on the growth of lung cancer cells with Met amplification Tumor cells were continuously treated with increasing.

M M M M 5. Not Listed

A B Supplementary Figure S1. T790M CTC PointMan genotyping assay. (A) Test characteristics of PointMan CTC T790M genotyping assay. The assay was validated.

Supplemental Table 1. Phenotypes in sleepy1 mutants. Fertility (number of seeds/one silique) Stem (cm) (after 60 days) Leaf (color) sly1-t2 (WS)dark green19.7.

營建工地的噪音第十組組員 : 蘇敏益 4970N014 徐鴻廣 4970N024 林孟賢 4970N012 葉書甫 4970N013.

Figure1 HER2 SKBr3 PC3 A. SKBr3 cells Figure (µM) Penetratin control % of control (µM)

Supplementary Figure S1 a

Progesterone receptor

500 mg total protein /mL S-CM 250 mg total protein /mL S-CM

Drug concentration (μM)

ProNGF Correlates with Gleason Score and Is a Potential Driver of Nerve Infiltration in Prostate Cancer Jay Pundavela, Yohann Demont, Phillip Jobling,

A Untreated mM maphos, 48h 20 mM maphos, 48h 50 mM maphos, 48hh B

Supplemental Figures Supplemental Figure 1.

Yongping Shao, Kaitlyn Le, Hanyin Cheng, Andrew E. Aplin

Volume 8, Issue 1, Pages (July 2014)

Analysis of CD151 and CD147 as potential prostate cancer biomarkers.

Fig. 1. Potent and selective down-regulation of KRAS mRNA and protein by AZD4785 in vitro and in vivo. Potent and selective down-regulation of KRAS mRNA.

Supplementary Table 1 Akt2 is required for NNK-induced lung tumorigenesis but not for urethane-induced lung tumorigenesis while Akt3 may act as a tumor.

Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells by Sergey Krysov, Samantha Dias, Alex Paterson, C.

Dhruva K. Mishra, PhD, Steven D. Compean, BS, Michael J

A B Figure S1 DU145 PC-3 22Rv1 RWPE-1 BPH1 Relative levels

Suppl. Figure 1 A B C D #### #### **** **** & && #### #### **** **** &

The Circadian Gene Period2 Plays an Important Role in Tumor Suppression and DNA Damage Response In Vivo Loning Fu, Helene Pelicano, Jinsong Liu, Peng.

FLAG β-actin p53 SET M.w. kDa D β-actin p53 G9a

Supplementary Figure 1 Non-migrating cells Migrating cells

Figure S2 Supplementary data a b CCA1 CCA2 CCA4 CCA3 CCA5 EGFR HER2

palpable tumor in nudes

Figure S1 Figure S2.

Volume 19, Issue 3, Pages (March 2014)

Supplementary Figure 1 a b c d e 1 2 cGMP levels (pmol/ml) vehicle

Volume 21, Issue 12, Pages (December 2017)

Supplementary Figure S4

Reh cells, 24 hours c-Myc Ac-p53 b-actin

20S proteasome activities

Supplemental Figure 6 Supplemental Figure 6. Treatment with erlotinib plus TAS-115 inhibits the growth of PC-9/HGF tumors in vivo. (A, B) Nude mice bearing.

Volume 26, Issue 5, Pages e6 (January 2019)

Volume 18, Issue 5, Pages (May 2010)

Inhibition of the Epidermal Growth Factor Receptor Suppresses Telomerase Activity in HSC-1 Human Cutaneous Squamous Cell Carcinoma Cells Arief Budiyanto,

Vehicle Akti 0’ 2’ 5’ 10’ 0’ 2’ 5’ 10’ AktT308 β-actin GSK3βS9 β-actin

Silencing Ifngr1 in the CMT167 line confers decreased response to IFNγ in vitro and in vivo. Silencing Ifngr1 in the CMT167 line confers decreased response.

Nikole J. Byrne et al. BTS 2017;j.jacbts

Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.

Supplemental Figure 1 Cell proliferation (% of mock)

Fig. 4 High P-eIF2α expression in human prostate tumors with loss of PTEN function is associated with increased risk of metastasis or death after surgery.

Shipra Das, Olga Anczuków, Martin Akerman, Adrian R. Krainer

Supplement Figure.1.

Silencing Socs1 in the LLC line confers increased response to IFNγ in vitro and in vivo. Silencing Socs1 in the LLC line confers increased response to.

Fig. 1. Potent and selective down-regulation of KRAS mRNA and protein by AZD4785 in vitro and in vivo. Potent and selective down-regulation of KRAS mRNA.

Effects of DPM treatment on tumor volume, tumor mass, and pulmonary metastasis at experimental end point. Effects of DPM treatment on tumor volume, tumor.

PD and efficacy of AZD4785 in KRAS mutant lung cancer xenograft models

The effect of a DIO regimen ± EPA+DHA supplementation on tumor growth.

MYC expression is correlated with dasatinib sensitivity in cancer cell lines and in vivo. MYC expression is correlated with dasatinib sensitivity in cancer.

Knockdown of ROR1 increases the invasive potential of melanoma cells in vitro and in vivo. Knockdown of ROR1 increases the invasive potential of melanoma.

Fig. 2. In vivo local CD25-targeted NIR-PIT induces regression of treated LL/2-luc tumors. In vivo local CD25-targeted NIR-PIT induces regression of treated.

Presentation transcript:

Supplemental Figure 1 A B C

Supplemental Figure 2 57 kDa 70 kDa c-myc β-actin 42 kDa RWPE-1 DU-145 PC-3 PC-3-ML AR-CaP-E AR-CaP-M c-myc β-actin 42 kDa

Supplemental Figure 3 A B

Supplemental Figure 4 pPEG-Luc pAEG-Luc 24h 48h 24h 48h D V L R PC3-ML PCa-1 PCa-2 PCa-3 PC3-ML PCa-1 PCa-2 PCa-3 PCa-4 Control Ctrl-1 Ctrl-2 Ctrl-3 Control Ctrl-1 Ctrl-2 Ctrl-3

Supplemental Figure 5 (Normalized ng Luc pDNA)/(100ng gDNA) AEG-Prom treated PCa Lungs Tumor PEG-Prom treated NS

Supplemental Figure 6 T A B C D E Gross H&E IHC(Anti-Luc) Pathology In-vivo BLI Ex-vivo BLI Gross H&E IHC(Anti-Luc) Pathology A B C D T E

Supplemental Figure 7 A B PC3-ML Control PCa-1 Ctrl-1 PCa-2 Ctrl-2

Supplemental Figure 8 L2 B A L2 L1 L3, L4 L5 C